Technology area: Biotechnology & Pharmaceuticals
3 pending office actions • 3 art units • 3 examiners • 0 of 3 (0%) have an AI response strategy ready • 4 patents granted in the last 365 days
Capsugel Belgium NV has 3 pending office actions in Biotechnology & Pharmaceuticals. The matters are distributed among 3 examiners and 3 art units, indicating separate examination contexts for the current docket.
SAEED, ALI S is the busiest examiner, with 1 pending office action. The equal examiner and art-unit counts support a file-specific response strategy, with no stated examiner concentration beyond one action.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 1 (33%) |
| Multi-statute (no §101) | 2 (67%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| SAEED, ALI S | 1 | 31.6% | +33.8% |
| HELM, CARALYNNE E | 1 | 28.9% | +49.8% |
| GOTFREDSON, GAREN | 1 | 39.9% | +28.1% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 19113166 | LIGHT-SHIELDING HARD CAPSULE CONTAINING MAGNESIUM OXIDE | SAEED, ALI S | — |
| 17665680 | Extended Release Vitamin C and Manufacturing Thereof | HELM, CARALYNNE E | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 3 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17604994 | FILM, CAPSULE AND FILM-FORMING COMPOSITION COMPRISING WATER-SOLUBLE SALT AS OPACIFYING AGENT | GOTFREDSON, GAREN | 17d overdue |
| 19113166 | LIGHT-SHIELDING HARD CAPSULE CONTAINING MAGNESIUM OXIDE | SAEED, ALI S | — |
| 17665680 | Extended Release Vitamin C and Manufacturing Thereof | HELM, CARALYNNE E | — |
| Art Unit | Apps |
|---|---|
| 1616 | 1 |
| 1615 | 1 |
| 1619 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 19113166 | LIGHT-SHIELDING HARD CAPSULE CONTAINING MAGNESIUM OXIDE | SAEED, ALI S | 1616 | §103§112 | Non-Final OA | — | Pending | Mar 19, 2025 |
| 17665680 | Extended Release Vitamin C and Manufacturing Thereof | HELM, CARALYNNE E | 1615 | §103§112 | Non-Final OA | — | Pending | Feb 07, 2022 |
| 17604994 | FILM, CAPSULE AND FILM-FORMING COMPOSITION COMPRISING WATER-SOLUBLE SALT AS OPACIFYING AGENT | GOTFREDSON, GAREN | 1619 | §103 | Non-Final OA | 17d overdue | Pending | Oct 19, 2021 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialCapsugel Belgium NV has 3 pending office actions as of October 2026, spread across 3 art units and 3 examiners.
Ali S Saeed has the most, with 1 of Capsugel Belgium NV's pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
